Skip to main content

Find Clinical Trials

Home
Conditions
Mast Cell Activation Disorders

Clinical trial condition

Mast Cell Activation Disorders

Explore clinical trials studying Mast Cell Activation Disorders. Study availability and eligibility vary by location and protocol.

93 public trials 18 recruiting studies

Refine in advanced search Browse all conditions

Mast Cell Activation Disorders trial results

Completed

Brentuximab Vedotin in Treating Patients With Advanced Systemic Mastocytosis or Mast Cell Leukemia

NCT01807598

Conditions: Aggressive Systemic Mastocytosis, Hematologic Diseases, Hemic and Lymphatic Diseases, +14 more
Locations: Stanford University, School of Medicine Stanford, California, United States

MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Efficacy of AB1010 in Patients With Systemic Indolent Mastocytosis

NCT00831974

Conditions: Immune System Diseases, Mast Cell Activation Disorders, Mastocytosis, +4 more
Locations: Not specified

View Trial Details

Completed

Masitinib in Patients With Mastocytosis With Handicap and Bearing the D816V Mutation

NCT01266369

Conditions: Immune System Diseases, Mast Cell Activation Disorders, Mastocytosis, +4 more
Locations: Not specified

View Trial Details

Completed

Efficacy and Safety of Midostaurin in Patients With Aggressive Systemic Mastocytosis or Mast Cell Leukemia

NCT00782067

Conditions: Aberrant Motor Behavior in Dementia, Aggression, Behavior, +16 more
Locations: University of California at Los Angeles Dept. of Hematology Clinic Los Angeles, California, United States

Stanford University Medical Center Stanford University 2 Stanford, California, United States

Georgia Health Sciences University Dept.ofMedicalCollegeOfGeorgia Augusta, Georgia, United States

Dana Farber Cancer Institute Hematology / Oncology Boston, Massachusetts, United States

View all 29 locations

View Trial Details

Completed

Phase 2 Midostaurin in Aggressive Systemic Mastocytosis and Mast Cell Leukemia

NCT00233454

Conditions: Aberrant Motor Behavior in Dementia, Aggression, Behavior, +19 more
Locations: Stanford University School of Medicine Stanford, California, United States

Dana Farber Cancer Institute Boston, Massachusetts, United States

Washington University-St. Louis St Louis, Missouri, United States

View Trial Details

Completed

Deferasirox in Treating Iron Overload Caused By Blood Transfusions in Patients With Hematologic Malignancies

NCT01273766

Conditions: Acute Undifferentiated Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, +206 more
Locations: Comprehensive Cancer Center of Wake Forest University Winston-Salem, North Carolina, United States

View Trial Details

Completed

Collecting and Storing Malignant, Borderline Malignant Neoplasms, and Related Samples From Young Patients With Cancer

NCT00898079

Conditions: Acute Undifferentiated Leukemia, Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative, Bone Marrow Diseases, +43 more
Locations: Children's Hospital of Alabama Birmingham, Alabama, United States

University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States

Phoenix Childrens Hospital Phoenix, Arizona, United States

Arkansas Children's Hospital Little Rock, Arkansas, United States

View all 192 locations

View Trial Details

Completed

Massage Therapy Given by Caregiver in Treating Quality of Life of Young Patients Undergoing Treatment for Cancer

NCT01053494

Conditions: Accelerated Phase Chronic Myelogenous Leukemia, Acute Undifferentiated Leukemia, Amyloidosis, +170 more
Locations: Wake Forest University Health Sciences Winston-Salem, North Carolina, United States

View Trial Details

Completed

Phase 2 Trial of Prophylactic Rituximab Therapy for Prevention of CGVHD

NCT00186628

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +16 more
Locations: Stanford University School of Medicine Stanford, California, United States

View Trial Details

Completed

Stem Cell Transplantation to Treat Systemic Mastocytosis

NCT00006413

Conditions: Graft vs Host Disease, Immune System Diseases, Mast Cell Activation Disorders, +5 more
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States

View Trial Details